Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


VA - 29107 - Genomic Medicine Program Advisory Committee - Agency Authority
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameGenomic Medicine Program Advisory CommitteeAgency NameDepartment of Veterans Affairs
Fiscal Year2020Committee Number29107
Original Establishment Date2/23/2006Committee StatusChartered
Actual Termination Date Committee URL 
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*13
Current Charter Date3/23/2020Designated Fed Officer Position Title*Program Manager, Million Veteran Program, Office of Research and Development Services
Date Of Renewal Charter3/23/2022Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Jennifer
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Moser
Establishment Authority*Agency AuthorityDesignated Federal Officer SuffixPh.D.
Specific Establishment Authority*38 USC 527Designated Federal Officer Phone*(202) 443-5678
Effective Date Of Authority*2/23/2006Designated Federal Officer Fax*(202) 495-6156
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*jennifer.moser@va.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNo
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*Goal 1: Veterans choose VA for easy access, greater choices, and clear information to make informed decisions
• Committee Goal 1: Evaluate the current state of genetic testsing and counseling within the VA and identify andy areas of focus or needs for program expansion. Particularly as it relates to the return of research reseults and Precision Oncology. The goal is to make genetics services in the VA accessible to more Veterans to benefit health care decision making.

• Committee Goal 3: Evaluate the return of research results efforts, including MVP ROAR, projects, precision oncology, and PHASeR (VA Pharmacogenomics Action for Cancer Survivorship) in order to make recommendations on next steps for broader implementation of genetics data into VA clinical decision making.

Goal 2: Veterans receive timely and integrated care and support that emphasizes their well-being and independence throughout their life journey—
• Committee Goal 1: Evaluate the current state of genetic testsing and counseling within the VA and identify andy areas of focus or needs for program expansion. Particularly as it relates to the return of research reseults and Precision Oncology. The committee would like to make sure that useful genetics information is implenented into health care decision making for all Veterans. In order to do this, the committee and associated subcommittee we must assesss the current state of those services within the VHA and make recommendations for improvement.

• Committee Goal 3: Evaluate the return of research results efforts, including MVP ROAR, projects, precision oncology, and PHASeR (VA Pharmacogenomics Action for Cancer Survivorship) in order to make recommendations on next steps for broader implementation of genetics data into VA clinical decision making.

Goal 3: Veterans trust VA to be consistently accountable and transparent
• Committee Goal 1: Evaluate the current state of genetic testsing and counseling within the VA and identify andy areas of focus or needs for program expansion. Particularly as it relates to the return of research reseults and Precision Oncology. The committee would like to make sure that useful genetics information is implenented into health care decision making for all Veterans. In order to do this, the committee and associated subcommittee we must assesss the current state of those services within the VHA and make recommendations for improvement.


• Committee Goal 2: Make recommendations on ways to increase minority enrollment into genetics research, particularly the Million Veteran Program and clinical trials. VHA should endeavor to ensure that participation in biomedical research is accessible to as many Veterans as possible, particularly those traditionally underrepresented in research. VHA should be cognizant of any trust issues around these topics and help Veterans understand the importance of representation in biomedical research in order to help improve healthcare for all Veterans.

• Committee Goal 3: Evaluate the return of research results efforts, including MVP ROAR, projects, precision oncology, and PHASeR (VA Pharmacogenomics Action for Cancer Survivorship) in order to make recommendations on next steps for broader implementation of genetics data into VA clinical decision making

Goal 4: VA will modernize systems and focus resources more efficiently to be competitive and to provide World Class capabilities to Veterans and its employees—
• Committee Goal 1: Evaluate the current state of genetic testsing and counseling within the VA and identify andy areas of focus or needs for program expansion. Particularly as it relates to the return of research reseults and Precision Oncology. Improving access to genetic testing and genomics services could help VHA be a healthcare service of choice for many Veterans.

• Committee Goal 3: Evaluate the return of research results efforts, including MVP ROAR, projects, precision oncology, and PHASeR (VA Pharmacogenomics Action for Cancer Survivorship) in order to make recommendations on next steps for broader implementation of genetics data into VA clinical decision making.
How is membership balanced?*Committee membership is balanced to ensure that all affected medical disciplines are represented. Membership includes those who can represent the interests of VA patients, VA employees, and VA medical facility administrators.
How frequent & relevant are cmte mtgs?*The Committee meets usually 2 to 3 times annually. Committee meetings focus on achieving the maximum benefit from VA's precision medicine/genomic medicine. There were 2 meetings held in FY2020, both virtual due to COVID-19 travel restrictions.
Why advice can't be obtained elsewhere?*The Committee is composed partially of private sector professionals who are experts in scientific research and provides a body of expertise that VA does not have now. It is also important to note that the Committee members' breadth of knowledge and experience is a critical component in the establishment of a national VA Genomic Medicine Program, assessing the potential impact of the Program regarding ongoing patient care services and the development of policies and procedures, standards of operation and guidelines consistent with applicable laws relevant to tissue collection, intellectual property rights and patient privacy.
Why close or partially close meetings?Meetings are open to the public unless indicated in accordance with the Government in the Sunshine Act.
Recommendation Remarks
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*NoneDollar Value Of Grants Recommended$0.00
Cost Savings CommentNAGrants Review CommentNo grants were reveiwed
Number Of Recommendations*31Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThis is the total number of recommendations from FY2006 through FY2020.The following recommendations were made in FY 2020:1. pursue strategies to increase diversity and inclusivity in VA genetics research 2. increase number of MVP projects to 100+ 3. pursue strategies to increase Veterans' access to genetics and genomics servicesAccess Agency WebsiteYes
% of Recs Fully Implemented*100.00%Access Committee WebsiteNo
% of Recs Fully Implemented Comment1) engage with Office of Research and Development's Workgroup on Diversity and Inclusivity to provide recommendations (2) Guidance for MVP access will be issued in Spring 2021 and VA project applications will be accepted starting in Fall 2021 3) Recommendations from a subcommittee of VA genomics services will be presented to the parent committee.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented Comment0Access OtherNo
Agency Feedback*YesAccess CommentNA
Agency Feedback Comment*Presentation of updates on recommendations are provided at Committee meetings.Narrative Description*The Committee supports the VA medical care and research mission by making recommendations and guidance regarding the use of genomic information in research and patient care. In FY 20, the meetings focus were on MVP updates, including presentations from the program. There were also updates on return of research results and reports on the Subcommittee for Genomics Services.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$3,500.00Est Payments to Non-Fed Members Next FY*$6,000.00
Payments to Federal Members*$2,740.00Est. Payments to Fed Members Next FY*$5,048.00
Payments to Federal Staff*$19,388.00Estimated Payments to Federal Staff*$29,064.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$6,000.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$4,000.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$1,000.00
Other Costs$0.00Est. Other Costs Next FY*$1,200.00
Total Costs$25,628.00Est. Total Next FY*$52,312.00
Federal Staff Support (FTE)*0.20Est. Fed Staff Support Next FY*0.30
Cost Remarkscosts are lower than anticipated because meetings were virtual, which decreased travel costs and meeting costs.Est Cost Remarkswe anticipate that the fall 2021 meeting will be able to be in person, so will incur travel costs and meeting space costs, and increased federal personnel time to handle the increased travel and meeting logistics.
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Medical Education
Aging
Medicine
Diseases
Health and Health Research
Illnesses
Research
Research and Development
Veterans
Veterans and Veterans' Medical Care
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-035955Genomic Medicine Program Advisory Committee2019
 COM-033605Genomic Medicine Program Advisory Committee2018
 COM-001864Genomic Medicine Program Advisory Committee2017
 COM-003102Genomic Medicine Program Advisory Committee2016
 COM-003372Genomic Medicine Program Advisory Committee2015
 COM-005180Genomic Medicine Program Advisory Committee2014
 COM-006109Genomic Medicine Program Advisory Committee2013
 COM-007331Genomic Medicine Program Advisory Committee2012
 COM-008212Genomic Medicine Program Advisory Committee2011
 COM-009458Genomic Medicine Program Advisory Committee2010
 COM-009688Genomic Medicine Program Advisory Committee2009
 COM-011381Genomic Medicine Program Advisory Committee2008
 COM-011557Genomic Medicine Program Advisory Committee2007
 COM-013229Genomic Medicine Program Advisory Committee2006